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Postoperative atrial fibrillation (POAF) is a 
common complication after cardiac surgery, which 
is associated with a longer hospital stay, and it 
may lead to the development of stroke, heart 
failure, and thromboembolic events [1]. The 
pathophysiology POAF is complex and involves 
several factors, including ischemia, inflammation, 
oxidative stress, sympathetic activation, and atrial 
distension [1,2]. Cardiopulmonary bypass (CPB) 
and ischemic reperfusion injury are associated 
with an inflammatory process and oxidative stress 
that may lead to cardiac tissue remodeling, cardiac 
function impairment, and development of POAF 
[3,4]. Several studies have shown that some 
antioxidants such as vitamin C, vitamin E, 
polyunsaturated fatty acids (PUFAs) and N-acetyl 
cysteine could reduce the incidence of POAF and 
can be used for prevention [5-9]. Alpha-lipoic acid 
(ALA) is an antioxidant that has many properties 
including the decrease of reactive oxygen species, 
regeneration of endogenous antioxidants such as 
vitamin C and glutathione, prevention of lipid and 
protein peroxidation and decreasing oxidative 
stress [10,11] and it was reported that ALA could 
prevent cardiac dysfunction in some animal 
studies [12-14]. Glutathione is an endogenous 
intracellular antioxidant, while malondialdehyde
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Abstract 
Background: Postoperative atrial fibrillation (POAF) is associated with increased 
morbidity and mortality, and an inflammatory process is involved in its 
pathogenesis. We aimed to study the possible effect of alpha-lipoic acid (ALA) as an 
antioxidant on atrial fibrillation after cardiac surgery. 
Methods: The study included ninety patients who underwent cardiac surgery, 
either valvular or coronary artery bypass grafting using cardiopulmonary bypass, 
and were randomized into two groups: Control and ALA groups. Blood samples were 
obtained to measure preoperative and postoperative levels of malondialdehyde 
(MDA), glutathione, C-reactive protein (CRP) and interleukin-6 (IL-6). The patients 
were monitored for the occurrence of atrial fibrillation until the day of discharge. 
Results: POAF occurred in 33% in the control group versus 11% in the ALA group 
(p=0.011).  When compared to the control group, ALA significantly decreased the 
postoperative levels of MDA (4.78±0.91 vs. 5.36±1.03 nmol/ml; p= 0.006) CRP 
(19.44±3.14 vs. 26.56±6.29 mg/dl; p <0.001) and IL-6 (22.25±2.2 vs. 25.37±2.5 
pg/ml; p< 0.001) while glutathione level increased significantly in patients who 
received ALA (26.4±4.59 vs. 23.44±5.11 mg/l; p= 0.005). 
Conclusion: ALA may help in the prevention of atrial fibrillation following cardiac 
surgery through exerting antioxidant and anti-inflammatory effects. 
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Table 1: The clinical pre-operative and operative data of both control and ALA groups. Continuous data are presented 
as mean and standard deviation and categorical data as number and percent. 
Parameter Control group (n= 45) ALA group (n= 45) p-value 
Age (years) 43.07±13.53 41.13±14.16 0.549 
Gender M/F 26/19 27/18 0.849 
Hypertension  14 (31%) 13 (29%) 0.818 
Diabetes Mellitus  10 (22%) 11 (24%) 0.803 
Heart rate (beat/min) 77±12 76±12 0.688 
Ejection fraction % 61.2±9.7 62.4±8.5 0.528 
Left atrial diameter (mm) 44.4±6.4 43±7.6 0.349 
Surgery 
CABG 17 (38%) 18 (40%) 
0.829 
Valvular surgery 28 (62%) 27 (60%) 
Aortic clamp time (min) 69.5±25.69 70.89±23.46 0.801 
CPB time (min) 90.4±37.05 92.56±33.65 0.773 
Preoperative MDA (nmol/ml) 3.89±0.82 3.98±0.79 0.576 
Preoperative glutathione (mg/dl) 30.15±6.2 30.8±5.5 0.602 
Preoperative CRP (mg/L) 6.75±2 7.92±1.4 0.641 
Preoperative IL-6 (pg/ml) 18.6±2 18.54±1.45 0.873 
ALA: Alpha-lipoic acid; MDA: malondialdehyde; CABG: coronary artery bypass grafting; CPB: 
cardiopulmonary bypass; CRP:C-reactive protein, IL-6: interleukin-6 
(MDA) results from polyunsaturated fatty acid 
peroxidation, and measurement of glutathione 
and MDA can reflect the oxidative stress status. 
On the other hand, C-reactive protein (CRP) and 
interleukin-6 (IL-6) are inflammatory markers that 
may affect the development of POAF [4]. 
The effect of ALA on postoperative AF has not 
well-established clinically. Therefore, the 
objectives of our study were to investigate the 
impact of ALA as an antioxidant on oxidative stress 
and the inflammatory process in patients 
undergoing on-pump cardiac surgery and its effect 
on POAF. 
Patients and Methods: 
This randomized controlled clinical study was 
performed in the Cardiothoracic Surgery 
Department in our university hospital after the 
approval of the research ethics committee, and 
the patients' consent was obtained before 
randomization. We included patients with normal 
sinus rhythm undergoing primary cardiac valve 
surgery or coronary artery bypass grafting (CABG). 
We excluded patients with a history of atrial 
fibrillation (AF), congenital heart disease, 
conditions that alter oxidative stress status, and 
induce inflammation such as cancer and recent 
infection, administration of corticosteroid, or non-
steroidal anti-inflammatory drugs, off-pump 
technique and emergency or redo surgery. No 
posterior pericardiotomies were carried out in any 
of the patients in both groups. 
Our study included ninety patients who were 
randomized into two groups: the control group (n= 
45) who received the placebo and the ALA group
(n= 45) who received alpha-lipoic acid. ALA was 
given in a dose of 600mg twice daily starting 5-10 
days before surgery and continued when oral 
intake is allowed after surgery till the day of 
discharge. 
Venous blood samples were obtained 
preoperatively (before administration of placebo 
or ALA) and postoperatively (48 hours after 
surgery) to measure the following biochemical 
parameters: blood glutathione level which was 
measured according to Chavan and colleagues 
method [15]; serum malondialdehyde (MDA) was 
determined as thiobarbituric acid reactive 
substances (TBARS) depending on the method of 
Draper and Hadley [16]; Interleukin-6 (IL-6) was 
measured using Elisa kit (Raybiotech Inc, USA), and 
C-reactive protein (CRP) levels which were 
determined by quantitative turbidimetric method 
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Table 2: The changes in oxidative stress and inflammatory markers before and after surgery. Continuous data are 
presented as mean and standard deviation. 
Parameter 
Control group (n=45) ALA group (n=45) 
Preoperative Postoperative P Preoperative Postoperative P 
MDA (nmol/ml) 3.89±0.82 5.36±1.03 <0.001 3.98±0.79 4.78±0.91 <0.001 
Glutathione (mg/L) 30.15±6.2 23.44±5.11 <0.001 30.8±5.5 26.4±4.59 <0.001 
CRP (mg/L) 6.75±2 26.56±6.29 <0.001 7.92±1.4 19.44±3.1 <0.001 
IL-6 (pg/ml) 18.6±2 25.37±2.5 <0.001 18.54±1.4 22.25±2.2 <0.001 
ALA: Alpha lipoic acid, MDA: malondialdhyde, CRP:C-reactive protein, IL-6: interleukin-6. 
using commercial kits (Spinreact, Ctra Santa 
Colona, Spain). 
Statistical Analysis 
SPSS version 15 (IBM Corp- Chicago- IL, USA) 
was used for data analysis. The Chi-square test 
(X2) was used for the comparison of qualitative 
data. The t-test was to compare the means of 
quantitative data of the two groups and paired t-
test for comparison of data within the same group 
before and after surgery. Kaplan-Meier survival 
curve was used to determine the cumulative 
incidence of POAF in each group, and the survival 
curves of the two groups were compared using the 
log-rank test. A p-value of less than 0.05 was 
considered statistically significant. 
Results 
The study included ninety patients with a 
mean age of 42± 14 years; 45 patients underwent 
valvular surgery, and 45 patients underwent 
CABG. Table 1 shows the clinical preoperative and 
operative data of both control and ALA groups. 
There was no significant difference regarding 
age, gender, history of hypertension, and diabetes 
mellitus between the two studied groups. The 
preoperative data, including heart rate, ejection 
fraction, and left atrial diameter, were not 
significantly different between control and ALA 
groups. The operative data were not significantly 
different regarding the type of surgery, aortic 
clamp, and CPB time, as shown in Table 1.   
Concerning oxidative stress markers, both 
control and ALA groups had no significant 
difference in preoperative MDA and glutathione 
levels. The preoperative levels of the 
inflammatory markers CRP and IL-6 were not 
significantly different between the two studied 
groups, as presented in (Table 1). 
The postoperative levels of MDA, CRP, and IL- 
6 significantly increased, and the postoperative 
glutathione significantly decreased in both control 
and ALA groups compared to their baseline 
preoperative data (p<0.001) as presented in 
(Table 2). However, the ALA group had 
significantly lower levels of postoperative MDA, 
CRP, and IL-6 and significantly higher levels of 
postoperative glutathione compared to their 
respective values in the control group, as shown 
in Table 3.  
The incidence of POAF was significantly 
decreased in the ALA group (11%) compared to in 
control group (33%) (Log-rank test p=0.01), as 
shown in the Kaplan-Meier survival curve for the 
occurrence of POAF in both control and ALA 
groups Figure 1.
Table 3: Effect of ALA on MDA, glutathione, CRP, and IL-6 levels. Data are presented as mean and standard deviation. 
Parameter Control group (n= 45) ALA group (n= 45) p-value 
Postoperative MDA (nmol/ml) 5.36±1.03 4.78±0.91 0.006 
Postoperative Glutathione (mg/L) 23.44±5.11 26.4±4.59 0.005 
Postoperative CRP (mg/L) 26.56±6.29 19.44±3.14 <0.001 
Postoperative IL-6 (pg/ml) 25.37±2.5 22.25±2.2 <0.001 
ALA: Alpha lipoic acid, MDA: malondialdhyde, CRP:C-reactive protein, IL-6: interleukin-6 
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Figure 1: Kaplan-Meier curve for the occurrence of 
post-operative atrial fibrillation in control and alpha 
lipoic acid groups (Log-rank p=0.01). 
Discussion 
Atrial fibrillation after cardiac surgery was 
linked to several predisposing factors, including 
old age, history of hypertension, diabetes, and left 
atrium diameter, cardiopulmonary bypass, and 
aortic clamp times [1,2]. Both control and ALA 
groups had no significant difference regarding all 
the previous factors. In this study, ALA significantly 
decreased the incidence of POAF compared to the 
control group, and it is consistent with other 
clinical studies which reported that perioperative 
supplementation of other several antioxidants 
including vitamin C, vitamin E, polyunsaturated 
fatty acids and N-acetyl cysteine reduced the 
incidence of atrial fibrillation after cardiac surgery 
[5-9]. Additionally, ALA significantly decreased 
the inflammatory markers, and the oxidative 
stress marker, and significantly increased the 
endogenous glutathione levels. 
Inflammatory reaction and oxidative stress 
play an essential role in the pathogenesis of POAF, 
and increased levels of inflammatory cytokines 
and oxidative stress were recorded in patients 
who had atrial fibrillation after cardiac surgery 
compared to other patients who did not have 
POAF [1,2].  
Surgical trauma, cardiopulmonary bypass, and 
ischemic reperfusion injury are the main triggering 
factors for tissue damage and the increase in the 
production of inflammatory mediators [3,4].  This 
explains the significant increase in postoperative 
levels of CRP and IL-6 in both control and ALA 
groups. 
High levels of inflammatory markers, including 
CRP, tumor necrosis factor-α (TNF-α), IL-6, and IL- 
1β, were associated with the development of 
POAF [4,17,18]. The release of inflammatory 
cytokines increases neutrophil migration and 
activation that leads to impairment of atrial 
conduction and diminishes the refractory period 
of cardiomyocytes leading to the development of 
atrial fibrillation [19]. The increase in the level of 
IL-6 during cardiac surgery starts after 10 minutes 
after the reperfusion and continues to increase 
[20]. IL-6 can negatively affect the cardiac 
function as it induces impairment in the 
myocardial contractile function, alters the 
response of cardiac β-adrenergic receptors, and 
induces left ventricular remodeling [21,22]. 
In our study, ALA significantly reduced the 
level of postoperative CRP and IL-6 compared to 
the control group, and this result is in agreement 
with Sardu and colleagues who reported that ALA 
administration significantly reduced the 
circulating levels of inflammatory markers in 
patients with atrial fibrillation after one year of 
catheter ablation [23]. This decrease in the level 
of inflammatory markers may be explained by 
ALA's ability to suppress the activation of redox-
sensitive transcription factor nuclear factor-κB 
(NF-κB) that regulates the expression of 
inflammatory cytokines [24]. 
Cardiopulmonary bypass and ischemic 
reperfusion injury are also associated with an 
increase in the production of reactive oxygen 
species and the development of oxidative stress 
[25]. This explains the significant increase in 
postoperative oxidative stress markers MDA and a 
considerable decrease in postoperative 
endogenous antioxidant glutathione in both 
control and ALA groups. The increased oxidative 
stress was reported to be associated with the 
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development of POAF [26]. Oxidative stress can 
lead to atrial cellular changes with disruption of 
electrical activity, shortening of the effective 
refractory period, and atrial remodeling that 
contribute to the development of POAF [27]. In 
addition, increased levels of reactive oxygen 
species increase the activation of   nuclear factor-
κB (NF-κB) and mitogen-activated protein kinase 
(MAPK) pathway, which results in increasing the 
inflammatory response and modulation apoptosis 
[28]. 
In the present study, ALA significantly 
decreased postoperative MDA levels and 
significantly increased postoperative glutathione 
levels compared to the control group, which is 
consistent with pre-clinical studies that reported 
that ALA could reduce MDA levels and decrease 
ischemic reperfusion injury [29].  
The increase in postoperative glutathione 
levels can be explained by the ability of ALA to 
recycle endogenous antioxidants [11] and 
increasing the synthesis of glutathione through 
enhancing cellular cysteine uptake that is 
necessary for glutathione synthesis [30]. On the 
other hand, the decrease of postoperative MDA 
levels can be explained by the antioxidant 
properties of ALA and increased endogenous 
glutathione levels. 
Our findings suggest that ALA antioxidants 
may reduce the occurrence of atrial fibrillation 
after open heart surgery as it reduced oxidative 
stress and inflammatory cytokines such as IL-6. 
Study limitations 
The study included small sample size, and the 
study period was short. It is recommended to 
perform other studies on a larger number of 
patients and for a longer period of follow up. It is 
preferred to study the effect of ALA on patients 
undergoing a single type of cardiac surgery, either 
CABG or valvular surgery. This is a single-center 
study, and generalization of the results may be an 
issue. 
Conclusion 
Alpha-lipoic acid may help in the prevention of 
atrial fibrillation following open-heart surgery 
through exerting antioxidant and anti-
inflammatory effects. 
Conflict of interest: Authors declare no conflict of 
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